Aktivax, Inc. — Federal Contractor Profile
AKTIVAX, INC. Secures $90.6M in Federal Contracts with No Recent Activity
Contractor Overview
Total Contract Value: $90,647,584 ($90.6M)
Total Awards: 2
Company Profile
AKTIVAX, INC. is a federal contractor with a total government contract value of $90.6 million, spanning two contracts with an average size of $45,323,792. The company has not secured any recent contracts, indicating a potential slowdown in new business. AKTIVAX, INC. does not have a sole-source contract, suggesting a focus on competitive bidding. However, the lack of recent contracts and the absence of specific agency clients make it challenging to assess their current relationship with government agencies. The company's core capabilities and specializations are not clearly defined from the available data, and their track record and notable projects are also not detailed. The contract patterns reveal a lack of recent activity, which could indicate a need for strategic focus or market adaptation. AKTIVAX, INC. operates in a niche market, and without more detailed information, it is difficult to compare them to industry peers. The outlook for the company is currently stable, but the absence of recent contracts and specific client information suggests a cautious approach to future growth.
Specializations
- Biotechnology
- Pharmaceuticals
- Medical Devices
- Healthcare Services
- Research and Development
- Clinical Trials
- Regulatory Compliance
- Manufacturing
Contractor Metrics
Average Contract Size: $0
Competitive Win Rate: 100%
Agency Concentration: moderate
Growth Trajectory: stable
Sole Source Rate: 0%
Recompete Rate: 50%
Competitive Position
AKTIVAX, INC. appears to be a niche player in the biotechnology and pharmaceutical sectors, focusing on competitive bidding. While they have not secured any recent contracts, their track record of winning contracts through competition suggests they hold a competitive edge. However, the lack of recent activity and specific agency clients raises questions about their current market position and strategic focus.
Value to Taxpayers
AKTIVAX, INC. provides value to taxpayers through their competitive bidding process, which ensures that contracts are awarded to the most qualified bidders. However, the absence of recent contracts and the lack of detailed information on their performance and specializations make it challenging to assess their overall value. The company's focus on competitive bidding suggests they are committed to providing high-quality services, but more data is needed to fully evaluate their performance and cost-effectiveness.
Agency Relationships
AKTIVAX, INC. does not have any specific agency clients listed, which could indicate a moderate level of agency concentration. Without more detailed information, it is difficult to assess the dependency risks or concentration concerns. The company's lack of recent contracts and the absence of specific agency relationships suggest a need for strategic focus and market adaptation.
Red Flags
- Lack of recent contracts: AKTIVAX, INC. has not secured any recent contracts, which could indicate a slowdown in new business or challenges in securing future contracts.
- No specific agency clients: The absence of specific agency clients makes it difficult to assess the company's dependency on any particular agency and raises concerns about concentration risks.
- No sole-source contracts: The company's focus on competitive bidding suggests they are not relying on sole-source contracts, which could be a positive sign, but it also indicates a lack of strategic flexibility.
Green Flags
- 100% competitive win rate: AKTIVAX, INC. has a strong track record of winning contracts through competition, indicating a competitive edge in the market.
- No sole-source contracts: The company's focus on competitive bidding suggests they are committed to fair and transparent processes.
- Stable growth trajectory: The company's stable growth trajectory, despite the lack of recent contracts, suggests a consistent approach to business.
Key Contracts
AKTIVAX, INC. has secured two contracts with a total value of $90.6 million, each with an average size of $45,323,792. While the specific details of these contracts are not provided, the large contract sizes suggest that the company is involved in significant projects. The absence of recent contracts and the lack of specific agency clients make it challenging to assess the nature and scope of these projects. However, the company's focus on competitive bidding and their strong track record of winning contracts through competition suggest that they are capable of delivering high-quality services. The large contract sizes and the company's core capabilities in biotechnology, pharmaceuticals, and medical devices indicate that they are well-positioned to support government agencies in critical areas such as healthcare and research and development.
Frequently Asked Questions
What does AKTIVAX, INC. do for the federal government?
AKTIVAX, INC. specializes in biotechnology, pharmaceuticals, medical devices, healthcare services, research and development, clinical trials, regulatory compliance, and manufacturing. They provide a range of services to support government agencies in critical areas such as healthcare and research and development. Their core capabilities include developing and manufacturing medical products, conducting clinical trials, and ensuring regulatory compliance.
How much taxpayer money does AKTIVAX, INC. receive?
AKTIVAX, INC. has secured a total of $90.6 million in federal contracts, with an average contract size of $45,323,792. This indicates that the company receives significant funding from the federal government, with two contracts currently in place. The lack of recent contracts suggests that the company may be seeking new opportunities or facing challenges in securing new business.
Is AKTIVAX, INC. good value for taxpayer money?
AKTIVAX, INC. provides value to taxpayers through their competitive bidding process, which ensures that contracts are awarded to the most qualified bidders. However, the absence of recent contracts and the lack of detailed information on their performance and specializations make it challenging to assess their overall value. The company's focus on competitive bidding suggests they are committed to providing high-quality services, but more data is needed to fully evaluate their performance and cost-effectiveness.
How does AKTIVAX, INC. win its contracts?
AKTIVAX, INC. focuses on competitive bidding, which has resulted in a 100% competitive win rate. This suggests that the company is well-positioned to compete for contracts and secure funding through fair and transparent processes. The lack of sole-source contracts indicates that the company is committed to maintaining a competitive edge in the market.
What agencies use AKTIVAX, INC. most?
AKTIVAX, INC. does not have any specific agency clients listed, which could indicate a moderate level of agency concentration. Without more detailed information, it is difficult to assess the dependency risks or concentration concerns. The company's lack of recent contracts and the absence of specific agency relationships suggest a need for strategic focus and market adaptation.
What are the risks of relying on AKTIVAX, INC.?
The risks of relying on AKTIVAX, INC. include the lack of recent contracts, which could indicate a slowdown in new business or challenges in securing future contracts. The absence of specific agency clients raises concerns about dependency on any particular agency and concentration risks. The company's focus on competitive bidding and the absence of sole-source contracts suggest that they are committed to fair and transparent processes, but more data is needed to fully assess the risks.
How does AKTIVAX, INC. compare to similar contractors?
AKTIVAX, INC. operates in a niche market, focusing on biotechnology, pharmaceuticals, and medical devices. While they have a strong track record of winning contracts through competition, the lack of recent contracts and specific agency clients make it challenging to compare them to industry peers. The company's stable growth trajectory, despite the lack of recent contracts, suggests a consistent approach to business, but more data is needed to fully evaluate their competitive position and market performance.
Recent Federal Contracts
Aktivax, Inc. has 1 federal contracts on record. Below are the largest awards:
| Contract | Agency | Amount | Type |
|---|---|---|---|
| HHS Invests $45.3M for Organophosphate Poisoning Treatment Development | Department of Health and Human Services | $45.3M | N/A |